Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide.
about
Novel strategies for systemic treatment of endometrial cancer.Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial.Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature reviewPeroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress.
P2860
Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@en
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@nl
type
label
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@en
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@nl
prefLabel
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@en
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@nl
P2093
P1433
P1476
Treatment of advanced and recu ...... rubicin, and cyclophosphamide.
@en
P2093
P304
P356
10.1016/0090-8258(91)90268-A
P407
P577
1991-05-01T00:00:00Z